Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Abdominal Aortic Aneurysm
Studies from C. Mitaka et al provide new data on abdominal aortic aneurysm
April 20th, 2008
According to recent research published in the journal Critical Care Medicine, "Ischemia-reperfusion injury is an important cause of renal dysfunction after abdominal aortic aneurysm repair. Human atrial natriuretic peptide (hANP) is a potent endogenous natriuretic, diuretic, and vasorelaxant peptide." "The objective of the present study was to evaluate the effects of hANP on renal function in patients undergoing abdominal aortic aneurysm repair. A prospective, randomized, placebo-controlled study Setting. Intensive care unit of a university hospital. Forty patients undergoing elective abdominal aortic aneurysm repair. The patients were randomized to receive a...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-20)
|
